Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women: Retrospective review of perinatal exposure to antiretroviral drugs in the perinatal aids collaborative transmission study

Annals of the New York Academy of Sciences

Volumn 918, Issue , 2000, Pages 212-221

  Bulterys, Marc ^a   Nesheim, Steven ^b   Abrams, Elaine J ^c   Palumbo, Paul ^d   Farley, John ^e   Lampe, Margaret ^a   Fowler, Mary Glenn ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MYOPATHY; PERINATAL MORBIDITY; PRENATAL EXPOSURE; PROGENY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; VIRUS TRANSMISSION;

EID: 0033638030     PISSN: 00778923     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1749-6632.2000.tb05491.x     Document Type: Article

References (14)

1. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States
2. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
3. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women
4. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine
5. Mitochondrial toxicity of antiviral drugs
6. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
7. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
8. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV
9. Trends in zidovudine prescription for pregnant women infected with HIV
10. Trends in perinatal transmission of HIV/AIDS in the United States
11. Prevention of HIV infection in children